{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:22:42Z","timestamp":1740147762666,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s12055-023-01642-0","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T07:02:10Z","timestamp":1702969330000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of cardiopulmonary bypass in patients with ischemic and hemorrhagic strokes in surgery for active infective endocarditis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9032-8557","authenticated-orcid":false,"given":"Takahiro","family":"Yamazato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Okita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"1642_CR1","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075\u2013123.","journal-title":"Eur Heart J."},{"key":"1642_CR2","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure. J Am Coll Cardiol. 2013;62:e147-239.","journal-title":"J Am Coll Cardiol"},{"key":"1642_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jtcvs.2016.09.093","volume":"153","author":"GB Pettersson","year":"2017","unstructured":"Pettersson GB, Coselli JS, Pettersson GB, Coselli JS, Hussain ST, Griffin B, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis: executive summary. J Thorac Cardiovasc Surg. 2017;153:1241-58.e29.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1642_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1253\/circj.CJ-19-0549","volume":"83","author":"S Nakatani","year":"2019","unstructured":"Nakatani S, Ohara T, Ashihara K, Izumi C, Iwanaga S, Eishi K, et al. JCS 2017 guideline on prevention and treatment of infective endocarditis. Circ J. 2019;83:1767\u2013809.","journal-title":"Circ J"},{"key":"1642_CR5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1473-3099(06)70631-4","volume":"6","author":"PJ Peters","year":"2006","unstructured":"Peters PJ, Harrison T, Lennox JL. A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis. 2006;6:742\u20138.","journal-title":"Lancet Infect Dis"},{"key":"1642_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/hrt.2003.029967","volume":"90","author":"F Delahaye","year":"2004","unstructured":"Delahaye F, C\u00e9lard M, Roth O, de Gevigney G. Indications and optimal timing for surgery in infective endocarditis. Heart. 2004;90:618\u201320.","journal-title":"Heart"},{"key":"1642_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0022-5223(95)70038-2","volume":"110","author":"K Eishi","year":"1995","unstructured":"Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745\u201355.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"1642_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1067\/mtc.2000.110191","volume":"120","author":"AM Gillinov","year":"2000","unstructured":"Gillinov AM, Lytle BW, Hoang V, Cosgrove DM, Banbury MK, McCarthy PM, et al. The atherosclerotic aorta at aortic valve replacement: surgical strategies and results. J Thorac Cardiovasc Surg. 2000;120:957\u201363.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"1642_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/icvts\/ivu039","volume":"18","author":"M Wilbring","year":"2014","unstructured":"Wilbring M, Irmscher L, Alexiou K, Matschke K, Tugtekin SM. The impact of preoperative neurological events in patients suffering from native infective valve endocarditis. Interact Cardiovasc Thorac Surg. 2014;18:740\u20137.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1642_CR10","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/01.STR.0000229894.28591.3f","volume":"37","author":"E Ruttmann","year":"2006","unstructured":"Ruttmann E, Willeit J, Ulmer H, Chevtchik O, H\u00f6fer D, Poewe W, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094\u20139.","journal-title":"Stroke"},{"key":"1642_CR11","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1161\/CIRCULATIONAHA.112.000813","volume":"127","author":"E Garc\u00eda-Cabrera","year":"2013","unstructured":"Garc\u00eda-Cabrera E, Fern\u00e1ndez-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, et al. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272\u201384.","journal-title":"Circulation"},{"key":"1642_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ejcts\/ezw035","volume":"50","author":"Y Okita","year":"2016","unstructured":"Okita Y, Minakata K, Yasuno S, Uozumi R, Sato T, Ueshima K, et al. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study. Eur J Cardiothorac Surg. 2016;50:374\u201382.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1642_CR13","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.athoracsur.2009.02.098","volume":"87","author":"E Shang","year":"2009","unstructured":"Shang E, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan M, et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg. 2009;87:1728\u201334.","journal-title":"Ann Thorac Surg"},{"key":"1642_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/ejcts\/ezt547","volume":"45","author":"D Yoshioka","year":"2014","unstructured":"Yoshioka D, Toda K, Sakaguchi T, Okazaki S, Yamauchi T, Miyagawa S. Valve surgery in active endocarditis patients complicated by intracranial haemorrhage: the influence of the timing of surgery on neurological outcomes. Eur J Cardiothorac Surg. 2014;45:1082\u20138.","journal-title":"Eur J Cardiothorac Surg."},{"key":"1642_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1213\/XAA.0000000000000665","volume":"10","author":"G Kiss","year":"2018","unstructured":"Kiss G, Braunberger E. Emergency valve replacement under minimal cardiopulmonary bypass for a patient with infective endocarditis and large brain hematoma: a case report. A A Pract. 2018;10:144\u20137.","journal-title":"A A Pract"},{"key":"1642_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4266\/acc.2021.01312","volume":"37","author":"JH Lee","year":"2022","unstructured":"Lee JH, Park JH, Jang JH, Kim SH, Hong SY, Heo W, et al. The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation. Acute Crit Care. 2022;37:177\u201384.","journal-title":"Acute Crit Care"},{"key":"1642_CR17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s13063-021-05760-1","volume":"22","author":"K Moon","year":"2021","unstructured":"Moon K, Hong KW, Bae IG. Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial. Trials. 2021;22:832.","journal-title":"Trials"},{"key":"1642_CR18","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1002\/ams2.585","volume":"7","author":"S Doi","year":"2020","unstructured":"Doi S, Akashi YJ, Takita M, Yoshida H, Morikawa D, Ishibashi Y, et al. Preventing thrombosis in a COVID-19 patient by combined therapy with nafamostat and heparin during extracorporeal membrane oxygenation. Acute Med Surg. 2020;7:e585.","journal-title":"Acute Med Surg"},{"key":"1642_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1527-3466.1995.tb00213.x","volume":"13","author":"K Okajima","year":"1995","unstructured":"Okajima K, Uchiba M, Murakami K. Nafamostat mesilate. Cardiovasc Drug Rev. 1995;13:51\u201365.","journal-title":"Cardiovasc Drug Rev"},{"key":"1642_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/09537109976040","volume":"10","author":"I Fuse","year":"1999","unstructured":"Fuse I, Higuchi W, Toba K, Aizawa Y. Inhibitory mechanism of human platelet aggregation by nafamostat mesilate. Platelets. 1999;10:212\u20138.","journal-title":"Platelets"},{"key":"1642_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/oxfordjournals.jbchem.a134611","volume":"95","author":"S Fujii","year":"1984","unstructured":"Fujii S, Yokoyama T, Ikegaya K, Yokoo N. New synthetic inhibitors of chymotrypsin. J Biochem. 1984;95:319\u201322.","journal-title":"J Biochem"},{"key":"1642_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1254\/jjp.35.203","volume":"35","author":"T Aoyama","year":"1984","unstructured":"Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, et al. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol. 1984;35:203\u201327.","journal-title":"Jpn J Pharmacol."},{"key":"1642_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1254\/fpj.84.417","volume":"84","author":"Y Koshiyama","year":"1984","unstructured":"Koshiyama Y, Ozeki M, Motoyoshi A, Fujita M, Iwaki M, Aoyama T. Pharmacological studies of FUT-175, nafamstat mesilate. IV. Effects on coagulation, platelets and fibrinolysis. Nihon Yakurigaku Zasshi. 1984;84:417\u201328.","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"1642_CR24","first-page":"M194","volume":"37","author":"T Sato","year":"1991","unstructured":"Sato T, Tanaka K, Kondo C, Morimoto T, Yada I, Yuasa H, et al. Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery. ASAIO Trans. 1991;37:M194\u20135.","journal-title":"ASAIO Trans"},{"key":"1642_CR25","doi-asserted-by":"publisher","first-page":"M395","DOI":"10.1097\/00002480-199207000-00063","volume":"38","author":"Y Miyamoto","year":"1992","unstructured":"Miyamoto Y, Nakano S, Kaneko M, Takano H, Matsuda H. Clinical evaluation of a new synthetic protease inhibitor in open heart surgery. Effect on plasma serotonin and histamine release and blood conservation. ASAIO J. 1992;38:M395-8.","journal-title":"ASAIO J."},{"key":"1642_CR26","first-page":"M545","volume":"39","author":"K Tanaka","year":"1993","unstructured":"Tanaka K, Kondo C, Takagi K, Sato T, Yada I, Yuasa H, et al. Effects of nafamostat mesilate on platelets and coagulofibrinolysis during cardiopulmonary bypass surgery. ASAIO J. 1993;39:M545\u20139.","journal-title":"ASAIO J"},{"key":"1642_CR27","first-page":"II432","volume":"88","author":"M Murase","year":"1993","unstructured":"Murase M, Usui A, Tomita Y, Maeda M, Koyama T, Abe T. Nafamostat mesilate reduces blood loss during open heart surgery. Circulation. 1993;88:II432-6.","journal-title":"Circulation."},{"key":"1642_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MAT.0000000000001216","volume":"67","author":"A Willers","year":"2021","unstructured":"Willers A, Swol J, Kowalewski M, Raffa GM, Meani P, Jiritano F, et al. Extracorporeal life support in hemorrhagic conditions: a systematic review. ASAIO J. 2021;67:476\u201384.","journal-title":"ASAIO J"},{"key":"1642_CR29","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/aor.14276","volume":"46","author":"F Sanfilippo","year":"2022","unstructured":"Sanfilippo F, Curr\u00f2 JM, La Via L, Dezio V, Martucci G, Brancati S, et al. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: a systematic review. Artif Organs. 2022;46:2371\u201381.","journal-title":"Artif Organs"},{"key":"1642_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000420222","volume":"93","author":"Y Ohtake","year":"1991","unstructured":"Ohtake Y, Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, et al. Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol. 1991;93:215\u20137.","journal-title":"Contrib Nephrol"},{"key":"1642_CR31","first-page":"253","volume":"32","author":"T Takahama","year":"1986","unstructured":"Takahama T, Kanai F, Hiraishi M, Onishi K, Yamazaki Z, Furuse A, et al. Application of a prostacyclin analogue (PG) and protease inhibitor (FUT) as anticoagulants with an LVAD system. ASAIO Trans. 1986;32:253\u20137.","journal-title":"ASAIO Trans"},{"key":"1642_CR32","first-page":"2166","volume":"41","author":"H Takano","year":"1993","unstructured":"Takano H, Miyamoto Y, Kaneko M, Matsuwaka R, Kuratani T, Amemiya A, et al. Experimental study on heparin-free cardiopulmonary bypass using nafamostat mesilate (FUT-175) and heparin-coated circuit. Nihon Kyobu Geka Gakkai Zasshi. 1993;41:2166\u201373.","journal-title":"Nihon Kyobu Geka Gakkai Zasshi"},{"key":"1642_CR33","first-page":"196","volume":"48","author":"Y Fukata","year":"1994","unstructured":"Fukata Y. Reduction in dose of heparin by combined use of nafamostat mesilate for the control of cardiopulmonary bypass. Iryo. 1994;48:196\u2013201.","journal-title":"Iryo"},{"key":"1642_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1067\/mtc.2001.111205","volume":"121","author":"E Ovrum","year":"2001","unstructured":"Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. J Thorac Cardiovasc Surg. 2001;121:324\u201330.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1642_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00540-009-0792-x","volume":"23","author":"YU Adachi","year":"2009","unstructured":"Adachi YU, Obata Y, Suzuki K, Katoh H, Itagaki T, Doi M, et al. Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model. J Anesth. 2009;23:624\u20137.","journal-title":"J Anesth"},{"key":"1642_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11748-003-0029-0","volume":"51","author":"K Nakamura","year":"2003","unstructured":"Nakamura K, Onitsuka T, Yano M, Yano Y, Matsuyama M, Niina K. Influence of heparin dosage on hemostasis under combined use of nafamostat mesilate during deep hypothermic circulatory arrest. Jpn J Thorac Cardiovasc Surg. 2003;51:186\u201391.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"1642_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1510\/icvts.2006.146209","volume":"6","author":"T Ota","year":"2007","unstructured":"Ota T, Okada K, Kano H, Okita Y. Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage. Interact Cardiovasc Thorac Surg. 2007;6:270\u20133.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1642_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jtcvs.2012.03.030","volume":"144","author":"N Morimoto","year":"2012","unstructured":"Morimoto N, Henmi S, Yoshida M, Mukohara N. Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke. J Thorac Cardiovasc Surg. 2012;144:726\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1642_CR39","first-page":"744","volume":"23","author":"T Sakamoto","year":"2014","unstructured":"Sakamoto T, Kano H, Miyahara S, Inoue T, Izawa N, Gotake Y, et al. Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke. J Heart Valve Dis. 2014;23:744\u201351.","journal-title":"J Heart Valve Dis"},{"key":"1642_CR40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s11748-021-01743-w","volume":"70","author":"T Yamazato","year":"2022","unstructured":"Yamazato T, Oyama N, Fujii T, Abe N, Ikemiya Y, YutakaTamashiro, et al. Aggressive early surgical strategy in patients with intracranial hemorrhage: a new cardiopulmonary bypass option. Gen Thorac Cardiovasc Surg. 2022;70:602\u201310.","journal-title":"Gen Thorac Cardiovasc Surg."},{"key":"1642_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0003-4975(95)00821-7","volume":"61","author":"GJ Despotis","year":"1996","unstructured":"Despotis GJ, Alsoufiev AL, Spitznagel E, Goodnough LT, Lappas DG. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses. Ann Thorac Surg. 1996;61:795\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1642_CR42","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/00000542-199910000-00031","volume":"91","author":"GJ Despotis","year":"1999","unstructured":"Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999;91:1122\u201351.","journal-title":"Anesthesiology"},{"key":"1642_CR43","first-page":"237","volume":"60","author":"S Yamamoto","year":"2007","unstructured":"Yamamoto S, Shichijo T, Yamane K, Terasaka K. Left atrial myxoma surgically resected in acute phase of hemorrhagic cerebral infarction; report of a case. Kyobu Geka. 2007;60:237\u201341.","journal-title":"Kyobu Geka"},{"key":"1642_CR44","first-page":"905","volume":"73","author":"A Furuta","year":"2020","unstructured":"Furuta A, Morimoto H, Mukai S, Futagami D, Kitaura J. Giant left atrial myxoma complicated with hemorrhagic cerebral infarction. Kyobu Geka. 2020;73:905\u20139.","journal-title":"Kyobu Geka"},{"key":"1642_CR45","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.athoracsur.2013.01.099","volume":"96","author":"S Yasuda","year":"2013","unstructured":"Yasuda S, Tokunaga S, Matsuki Y, Okamoto H, Machida D, Masuda M. Left atrium ball thrombus in a patient with hemorrhagic cerebral infarction. Ann Thorac Surg. 2013;96:2236\u20138.","journal-title":"Ann Thorac Surg"}],"container-title":["Indian Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12055-023-01642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12055-023-01642-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12055-023-01642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:04:39Z","timestamp":1717063479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12055-023-01642-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":45,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1007\/s12055-023-01642-0","relation":{},"ISSN":["0970-9134","0973-7723"],"issn-type":[{"type":"print","value":"0970-9134"},{"type":"electronic","value":"0973-7723"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"No ethics approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared that there are no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}